Postoperative Cognitive Dysfunction Completed Phase 2 Trials for Chloroxylenol (DB11121)

IndicationStatusPhase
DBCOND0036861 (Postoperative Cognitive Dysfunction)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs